Tracking health in children with PTEN gene changes
Part of Cancer, Genetic & congenital clinical trials.
This study follows children and their affected relatives who have a harmful change in the PTEN gene. The goal is to understand the health risks, especially the chance of developing cancer, over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed harmful change (pathogenic variant) in the PTEN gene.
- The patient must be under 18 years old, or you can be an adult relative with the same genetic change.
- You (or your child's legal guardian) must be willing to sign a consent form agreeing to take part.
- You must agree to complete all the tests and check-ups required by the study.
- You cannot have a non-harmful (benign) or uncertain PTEN change.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is creating a registry (a database) of children with PTEN Hamartoma Tumor Syndrome, a condition that can cause growths, large head size, and other health issues. By joining, you help doctors learn more about the condition and how to better care for kids like yours.
This study is looking at how people in families with certain TP53 gene changes (including Li-Fraumeni syndrome) develop health problems over time. It may help doctors better understand risk and improve care for affected families.
This study looks at how parents and children communicate after learning about an inherited (genetic) cancer risk. It may help researchers find better ways to support families in these conversations.
This trial tests if everolimus can improve social abilities in people with PTEN germline mutations who have social difficulties. It may help those with PTEN Hamartoma Tumor Syndrome by targeting a specific pathway in the body.
This study looks at inherited (family) risk for childhood cancers, including families with early cancers or known cancer risk conditions. It may help researchers understand why some children get cancer and improve future risk detection and care.
This trial tests ways to screen people who have a family-passed (inherited) gene mutation linked to higher pancreatic cancer risk. The goal is to find pancreatic cancer earlier and improve how screening is done for people at increased risk.
Hear when a new PTEN Hamartoma Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.